Agreement will utilise Oxford Biomedica’s LentiVector platform
New deal with Wockhardt boosts capacity at the crucial ‘fill and finish’ stage
Updated Date: Mon, 27 Jul 2020 00:00:00 EDT
Updated Date: Mon, 27 Jul 2020 00:00:00 EDT
Updated Date: Mon, 27 Jul 2020 00:00:00 EDT
Updated Date: Mon, 27 Jul 2020 00:00:00 EDT
Updated Date: Mon, 27 Jul 2020 00:00:00 EDT
Around 40% of dementia cases worldwide could have potentially been delayed or prevented if 12 risk factors had […]
An analysis of thousands of emails has shown the extent to which Coca-Cola sought to obscure its relationship […]
